【摘 要】
:
Objectives We sought to evaluate the efficacy and safety of a hypofractionated intensity-modulated radiotherapy (IMRT) regimen for pelvic-confined prostate cancer in prostatespecific antigen (PSA)-uns
【机 构】
:
Department of Radiation Oncology,Cancer Hospital and Institute,Chinese Academy of Medical Sciences (
论文部分内容阅读
Objectives We sought to evaluate the efficacy and safety of a hypofractionated intensity-modulated radiotherapy (IMRT) regimen for pelvic-confined prostate cancer in prostatespecific antigen (PSA)-unscreened Chinese patients.Methods We prospectively enrolled 140 prostate cancer patients (T1-4N0-1M0) on a phase Ⅱ protocol who were then treated with hypofractionated IMRT (2.7 Gy×25 fractions;total 67.5 Gy).High-risk patients (≥30 % probability of pelvic nodal involvement, 55 patients) and patients with pelvic nodal enlargement (25 patients) also received 50 Gy in 25 fractions to the pelvic lymph nodes.Outcomes and toxicity data were analyzed for all patients at a median follow-up of 35 months.Results The 3-year overall survival and biochemical recurrence-free survival (bRFS) rates were 94.6 and 89.1%, respectively.The bRFS at 3 years was 100 % for low/intermediate-risk patients, 89.6 % for high-risk patients,82.5 % for very high risk patients, and 73.5 % for those with N1 disease.Cumulative grade ≥2 Radiation Therapy Oncology Group late gastrointestinal (GI) and genitourinary (GU) toxicity at 3 years was 26.4 and 18.6 %, respectively.There were four grade 3 GI and seven grade 3 GU events and one grade 4 GI and one grade 4 GU event.At the last followup, 8.5 and 9.3 % of patients had late grade ≥2 GI and GU toxicity, respectively, and 1.4 and 2.9 % patients had late grade ≥3 GI and GU toxicity, respectively.Conclusion Moderately hypofractionated IMRT for prostate cancer is efficacious and well-tolerated in this predominantly high-risk, locally advanced, or N1 Chinese patients and is associated with low rates of severe late toxicity during early follow-up.
其他文献
慢性乙型肝炎原先一直是中医治疗的优势领域,在干扰素和核苷(酸)类似物抗病毒普及使用后,优势顿失.不仅如此,许多中医问题应该值得同仁们深思:在西医划定的范围内工作、疗效没有得到西医的认同;在逐渐认识到部分中药有肝损伤的副作用后,质疑不断,大有全盘否定中药在此领域作用之势,面对此境,中药如何配合抗病毒,如何既不失辨证论治之传统又逐步走向规范化,如何发扬抗肝纤维化之优势,这些都是需要深思的问题.
目的:寻找探索肝恶性肿瘤的临证诊治规律,以期更加全面的认识恶性肿瘤的发病特点和证候变化脉络,提高临床疗效.方法:肝癌为常见恶性肿瘤,是内外病因相互作用的结果,病机复杂,正虚与邪实随病情进展而演变,夹杂着病人阴阳气血、虚实寒热、脏腑经络、七情起伏、瘤体大小等,可因治而变,故中医治疗在整体观念和辨证论治指导下亦应因变而治.在继承前贤学术思想的基础上,结合临证心得和患者个体化差异,提出了肝恶性肿瘤的中医
文章介绍作者运用桂枝汤、五苓散等经方临床治疗各科疾病,通过临床实践,表明灵活运用经方确实能达到满意效果,中医经典著作值得深入研究.
目的:通过分析有关古今医案专辑、临床经验专着及期刊杂志中的五苓散医案,总结其男科运用方证规律.方法:对搜集到的符合研究要求的医案,进行多样本统计分析,归纳临床表现,探讨男科经方应用指征.结果:共收集医案60则,涉及前列腺增生等男科疾病16种.发现尿频或夜尿频多、排尿不畅、腰痛、小腹胀满、口渴、苔薄白等6项指标是本方男科运用的主要指征.结论:五苓散男科方证研究进一步拓展本方男科运用范围.
目的:探讨经典方治疗小儿急诊的应用与疗效.方法:通过经典方对小儿腹泻病、急性化脓性扁桃体炎、流行性感冒三案的案例分析.结果:经典方治疗小儿急诊有显着的疗效.结论:经典方治疗小儿急诊,只要抓住治疗时机,抓住主证,方证对应,同样也能发挥出意想不到的效果,反映出前贤的伟大诊疗实践经验与成果.
目的:根据近30年来小儿急性肾炎辨证及治法的进展.并结合临床进行补充.方法:对八十年代以来的重点中医儿科专著在对小儿急性肾炎的辨证及治法上进行对比分析.结果:疏风清热,宣肺利水法;辛凉透表,清热利水法;辛温解毒,通阳利水法;清热解毒,利湿消肿法;清热除湿,健脾利水法;渗湿利水消肿法;泻肺逐水,宁心安神法;平肝泻火,利湿开窍法;温补脾肾,化湿降浊法;健脾益肾,固肾补虚法;益肾养阴法;益气养阴法等均有
Purpose: To investigate whether single nucleotide polymorphisms (SNPs) in the ataxia telangiectasia mutated (ATM) gene are associated with survival in patients with esophageal squamous cell carcinoma
Background: The current study is the first to examine the effectiveness and toxicity of postoperative intensity-modulated radiotherapy (IMRT) in the treatment of intrahepatic cholangiocarcinoma (ICC)
Background: Little is known about the clinical use of intensity-modulated radio-therapy (IMRT) in postoperative radiotherapy (PORT) of esophageal cancer;there-fore, we retrospectively investigated the
In our center, the feasibility and related acute toxicities of hypofractionated helical tomotherapy have been evaluated in older aged patients with prostate cancer.Between February 2009 and February 2